LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
QSI
Quantum-Si incorporated
There isn't enough reported data to score QSI yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
QSI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Unavailable |
QSI's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
QSI PE Valuation
QSI has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
QSI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect QSI's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over QSI on earnings quality, reporting a profit while its opponent remains loss making.
QSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.38 | +$0.29 |
| Q2 2026 | -$0.45 | +$0.23 |
| Q1 2026 | -$0.50 | +$0.18 |
| Q4 2025 | -$0.51 | +$0.20 |
| Q3 2025 | -$0.67 | -$0.03 |
| Q2 2025 | -$0.68 | -$0.05 |
| Q1 2025 | -$0.68 | -$0.03 |
| Q4 2024 | -$0.71 | -$0.03 |
QSI is still losing money, but far less than before: $0.38 per share over the past year, against $0.95 at its worst in late 2022.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over QSI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over QSI on profitability, with a higher operating margin.
QSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $212K | -62% |
| Q2 2026 | $344K | -42% |
| Q1 2026 | $258K | -69% |
| Q4 2025 | $451K | -62% |
| Q3 2025 | $552K | -30% |
| Q2 2025 | $591K | -5% |
| Q1 2025 | $842K | +84% |
| Q4 2024 | $1.2M | +198% |
QSI's revenue has slid since its 2024 peak: $212,000 last quarter, down 62% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -11215% | -4010 points |
| Q2 2026 | -7450% | -2354 points |
| Q1 2026 | -9323% | -6341 points |
| Q4 2025 | -4677% | -2104 points |
| Q3 2025 | -7205% | -3636 points |
| Q2 2025 | -5096% | -844 points |
| Q1 2025 | -2982% | +2129 points |
| Q4 2024 | -2574% | +4397 points |
QSI's operating margin was −11215% last quarter, down 4010 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over QSI on cash generation, producing positive trailing cash flow while its opponent burns cash.
QSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$20.6M | +$12.3M |
| Q2 2026 | -$18.5M | +$2M |
| Q1 2026 | -$25.9M | +$1.5M |
| Q4 2025 | -$16.3M | +$8M |
| Q3 2025 | -$32.9M | -$8.8M |
| Q2 2025 | -$20.5M | -$844K |
| Q1 2025 | -$27.5M | -$3.2M |
| Q4 2024 | -$24.3M | -$3.7M |
QSI has burned cash in almost every quarter: −$81M over the past year, against −$105M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over QSI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
QSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +1.2M shares |
| 1 year | +4.8% | +9.9M shares |
| 3 years | +55% | +77.3M shares |
| 5 years | +3972% | +214M shares |
QSI has 219M diluted shares, up 4.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
QSI Net Leverage
QSI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
QSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.9 | Neutral |
| Stochastic | 57.2 | Neutral |
QSI's weekly RSI is 54 (neutral) and its Stochastic is 57 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
QSI PE vs Healthcare Sector
QSI has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over QSI on trend strength, trading above more of its moving averages.
QSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.31 | 6.9% below |
| 20 week MA | $1.00 | 22% above |
| 50 week MA | $1.02 | 20% above |
| 100 week MA | $1.36 | 10% below |
| 200 week MA | $1.48 | 18% below |
QSI's trend is mixed: it's above two of its five weekly moving averages, and 18% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over QSI on returns for 2026, with the stronger performance.
QSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.88 | $10.2 | +3% |
| 2021 | $10.2 | $8.16 | -20% |
| 2022 | $8.16 | $2.07 | -75% |
| 2023 | $2.07 | $2.01 | -2.9% |
| 2024 | $2.01 | $3.60 | +79% |
| 2025 | $3.60 | $1.23 | -66% |
| 2026 YTD | $1.23 | $1.22 | -0.8% |
QSI has finished lower in four of the last six years. It's down 0.8% so far in 2026.